Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esperanza Merino

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Antimicrobial Chemotherapy|October 7, 2024
Real-world effectiveness of early anti-SARS therapy in severely immunocompromised COVID-19 outpatients during the SARS-CoV-2 omicron variant era: a propensity score-adjusted retrospective cohort studyHéctor Pinargote-Celorio, Óscar Moreno-Pérez, Pilar González-De-La-Aleja, et al.
Frontiers in Pharmacology|October 26, 2023
A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence statusJosé Manuel Ramos-Rincón, Héctor Pinargote-Celorio, Jara Llenas-García, et al.
The Lancet. Respiratory Medicine|January 18, 2017
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trialFrancisco M Marty, Joan Vidal-Puigserver, Carol Clark, et al.
International Journal of Molecular Sciences|February 11, 2023
Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological SyndromesMatthew P Lennol, Nicholas J Ashton, Oscar Moreno-Pérez, et al.
The Journal of Infection|January 15, 2021
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort studyOscar Moreno-Pérez, Esperanza Merino, Jose-Manuel Leon-Ramirez, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|May 27, 2026
ASP-COMPLEX: redefining antimicrobial stewardship to improve outcomes in high-risk patients with severe infectionsJuan Pasquau, Francisco Javier Candel, José Luis Del Pozo, et al.
Journal of the International AIDS Society|November 15, 2014
Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER StudyJoaquín Portilla, Piedad Arazo, Josefa Crusells, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 12, 2022
[Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment]Héctor Pinargote-Celorio, Silvia Otero-Rodríguez, Pilar González-de-la-Aleja, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 30, 2021
Plasma ACE2 species are differentially altered in COVID-19 patientsMaría-Salud García-Ayllón, Oscar Moreno-Pérez, Juan García-Arriaza, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|April 1, 2023
Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatmentHéctor Pinargote-Celorio, Silvia Otero-Rodríguez, Pilar González-de-la-Aleja, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Antimicrobial Chemotherapy|October 7, 2024
Real-world effectiveness of early anti-SARS therapy in severely immunocompromised COVID-19 outpatients during the SARS-CoV-2 omicron variant era: a propensity score-adjusted retrospective cohort studyHéctor Pinargote-Celorio, Óscar Moreno-Pérez, Pilar González-De-La-Aleja, et al.
Frontiers in Pharmacology|October 26, 2023
A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence statusJosé Manuel Ramos-Rincón, Héctor Pinargote-Celorio, Jara Llenas-García, et al.
The Lancet. Respiratory Medicine|January 18, 2017
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trialFrancisco M Marty, Joan Vidal-Puigserver, Carol Clark, et al.
International Journal of Molecular Sciences|February 11, 2023
Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological SyndromesMatthew P Lennol, Nicholas J Ashton, Oscar Moreno-Pérez, et al.
The Journal of Infection|January 15, 2021
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort studyOscar Moreno-Pérez, Esperanza Merino, Jose-Manuel Leon-Ramirez, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|May 27, 2026
ASP-COMPLEX: redefining antimicrobial stewardship to improve outcomes in high-risk patients with severe infectionsJuan Pasquau, Francisco Javier Candel, José Luis Del Pozo, et al.
Journal of the International AIDS Society|November 15, 2014
Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER StudyJoaquín Portilla, Piedad Arazo, Josefa Crusells, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 12, 2022
[Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment]Héctor Pinargote-Celorio, Silvia Otero-Rodríguez, Pilar González-de-la-Aleja, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 30, 2021
Plasma ACE2 species are differentially altered in COVID-19 patientsMaría-Salud García-Ayllón, Oscar Moreno-Pérez, Juan García-Arriaza, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|April 1, 2023
Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatmentHéctor Pinargote-Celorio, Silvia Otero-Rodríguez, Pilar González-de-la-Aleja, et al.
Pageof 13